Patents by Inventor Zhongbin Wu

Zhongbin Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREPARATIONS OF TAXANES FOR INTRAVENOUS ADMINISTRATION AND THE PREPARATION METHOD THEREOF
    Publication number: 20190216768
    Abstract: The present invention relates to the field of medical technology. More specifically, the present invention relates to a preparation of taxanes for intravenous administration, which consists of two parts: a drug solution and an emulsion. Said drug solution consists of paclitaxel or docetaxel, a pH regulator and a solvent for injection, wherein said solvent for injection is an organic solvent. Said emulsion includes a fat emulsion and is composed of oil for injection, an emulsifier, an antioxidant, an isotonic regulator, a stabilizer, a pH regulator and water for injection. When used, the drug solution at the clinical dosage can be added and evenly mixed in the emulsion to perform intravenous drip directly; or the drug solution at the clinical dosage can also be firstly added into the emulsion with no less than 5 times volume of the drug solution and then a predetermined amount of normal saline or glucose solution for injection is added to perform intravenous drip.
    Type: Application
    Filed: March 21, 2019
    Publication date: July 18, 2019
    Applicant: JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD.
    Inventors: Jianming Chen, Baoan Gao, Jing Sun, Yue Zhang, Xiaoli Zheng, Ying Li, Dan Guo, Yang Zhang, Zhongbin Wu, Qiuxia Yang, Wei Liu, Peng Gu
  • PREPARATIONS OF TAXANES FOR INTRAVENOUS ADMINISTRATION AND THE PREPARATION METHOD THEREOF
    Publication number: 20170007570
    Abstract: The invention relates to a preparation of taxanes for intravenous administration consisting of a drug solution and an emulsion. The drug solution consists of paclitaxel or docetaxel, a pH regulator and an organic solvent for injection. The emulsion includes a fat emulsion and is composed of oil for injection, an emulsifier, an antioxidant, an isotonic regulator, a stabilizer, a pH regulator and water for injection. When used, the drug solution at the clinical dosage can be added and evenly mixed in the emulsion to perform intravenous drip directly; or the drug solution at the clinical dosage can also be firstly added into the emulsion with no less than 5 times volume of the drug solution and then a predetermined amount of normal saline or glucose solution for injection is added to perform intravenous drip. The preparation of the present invention does not contain solubilizer.
    Type: Application
    Filed: September 23, 2016
    Publication date: January 12, 2017
    Applicant: TASLY HOLDING GROUP CO., LTD.
    Inventors: Jianming Chen, Baoan Gao, Jing Sun, Yue Zhang, Xiaoli Zheng, Ying Li, Dan Guo, Yang Zhang, Zhongbin Wu, Qiuxia Yang, Wei Liu, Peng Gu
  • PREPARATIONS OF TAXANES FOR INTRAVENOUS ADMINISTRATION AND THE PREPARATION METHOD THEREOF
    Publication number: 20140045927
    Abstract: The present invention relates to the field of medical technology. More specifically, the present invention relates to a preparation of taxanes for intravenous administration, which consists of two parts: a drug solution and an emulsion. Said drug solution consists of paclitaxel or docetaxel, a pH regulator and a solvent for injection, wherein said solvent for injection is an organic solvent. Said emulsion includes a fat emulsion and is composed of oil for injection, an emulsifier, an antioxidant, an isotonic regulator, a stabilizer, a pH regulator and water for injection. When used, the drug solution at the clinical dosage can be added and mixed homogeneously in the emulsion to perform intravenous drip directly; or the drug solution at the clinical dosage can also be firstly added into the emulsion with no less than 5 times volume of the drug solution and then a predetermined amount of normal saline or glucose solution for injection is added to perform intravenous drip.
    Type: Application
    Filed: October 21, 2013
    Publication date: February 13, 2014
    Applicant: Tianjin Tasly Group Co., Ltd.
    Inventors: Jianming Chen, Baoan Gao, Jing Sun, Yue Zhang, Xiaoli Zheng, Ying Li, Dan Guo, Yang Zhang, Zhongbin Wu, Qiuxia Yang, Wei Liu, Peng Gu
  • Preparations of Taxanes for Intravenous Administration and the Preparation Method Thereof
    Publication number: 20110077291
    Abstract: The present invention relates to the field of medical technology. More specifically, the present invention relates to a preparation of taxanes for intravenous administration, which consists of two parts: a drug solution and an emulsion. Said drug solution consists of paclitaxel or docetaxel, a pH regulator and a solvent for injection, wherein said solvent for injection is an organic solvent. Said emulsion includes a fat emulsion and is composed of oil for injection, an emulsifier, an antioxidant, an isotonic regulator, a stabilizer, a pH regulator and water for injection. When used, the drug solution at the clinical dosage can be added and mixed homogeneously in the emulsion to perform intravenous drip directly; or the drug solution at the clinical dosage can also be firstly added into the emulsion with no less than 5 times volume of the drug solution and then a predetermined amount of normal saline or glucose solution for injection is added to perform intravenous drip.
    Type: Application
    Filed: September 30, 2009
    Publication date: March 31, 2011
    Inventors: Jianming Chen, Baoan Gao, Jing Sun, Yue Zhang, Xiaoli Zheng, Ying Li, Dan Guo, Yang Zhang, Zhongbin Wu, Qiuxia Yang, Wei Liu, Peng Gu